Preparation method of ziprasidone or its salt inclusion
A technology for ziprasidone and clathrates, which is applied in the field of preparation of ziprasidone mesylate clathrates, can solve problems such as hydrolysis, efficiency reduction, and water deterioration, and achieve low cost, high efficiency, and time-consuming short effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
preparation example Construction
[0038] The preparation method of the present invention is to add ziprasidone or its salt raw material, cyclodextrin and its derivatives into the solvent, heat and reflux at 78±1.0°C until the drug is completely dissolved; evaporate the solvent to obtain ziprasidone Water-soluble clathrates of ketones or their salts.
[0039] The ratio of the drug to the cyclodextrin affects the quality of the clathrate, and the molar ratio of the drug to the cyclodextrin in the present invention is 1.87±1.5:1, preferably 1.87:1.
[0040] The solvent used in the present invention is selected from: (i) ethanol (boiling point is 78.3 ℃); (ii) mixed solvents of ethanol and other solvents (such as acetonitrile, acetone, isopropanol (82.3 ℃), tetrahydrofuran); (iii) ethanol A mixed solvent with water; (iv) a mixed solvent consisting of (ii) and (iii). An aqueous ethanol solution is preferred, wherein the volume percentage of ethanol is 90-100%, preferably 95-100%, more preferably 99-100%.
[0041]...
Embodiment 1
[0062] Preparation of clathrate
[0063] Add 25.09 grams of ziprasidone mesylate hemihydrate and 752.7 grams of HPBCD to 4 liters of absolute ethanol, heat and reflux in a water bath at 78°C for 2 hours to fully dissolve and filter, and concentrate under reduced pressure to constant weight to obtain Drug-HPBCD inclusion complex. Add water to dissolve the above-mentioned clathrate, add water to 3 liters, filter through a 0.2-micron microporous membrane, pack in a can, and freeze-dry to obtain ziprasidone mesylate for injection.
[0064] The results showed that the clathrate obtained was white in color and high in purity (>99.7%).
Embodiment 2-4
[0067] Add 25.09 grams of ziprasidone mesylate hemihydrate and 752.7 grams of HPBCD with different contents in the above table to 4 liters, heat and reflux in a water bath at the temperature listed above for 2 hours to fully dissolve, Concentrate under reduced pressure to constant weight to obtain drug-HPBCD inclusion complex. Dissolve the clathrate with water, add water to 3 liters, filter through a 0.2-micron microporous membrane, pack in a can, and freeze-dry to obtain ziprasidone mesylate for injection.
[0068] result
PUM
Property | Measurement | Unit |
---|---|---|
boiling point | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com